Greenwich LifeSciences, Inc. (NASDAQ:GLSI – Get Rating) CEO Snehal Patel acquired 6,000 shares of Greenwich LifeSciences stock in a transaction that occurred on Tuesday, April 19th. The stock was purchased at an average cost of $16.74 per share, with a total value of $100,440.00. Following the completion of the purchase, the chief executive officer now owns 1,210,929 shares in the company, valued at approximately $20,270,951.46. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.
Snehal Patel also recently made the following trade(s):
- On Thursday, April 21st, Snehal Patel acquired 6,000 shares of Greenwich LifeSciences stock. The stock was purchased at an average cost of $16.09 per share, with a total value of $96,540.00.
- On Friday, February 11th, Snehal Patel acquired 5,500 shares of Greenwich LifeSciences stock. The stock was purchased at an average cost of $19.80 per share, with a total value of $108,900.00.
- On Friday, February 4th, Snehal Patel bought 5,000 shares of Greenwich LifeSciences stock. The stock was bought at an average price of $19.59 per share, with a total value of $97,950.00.
Shares of NASDAQ:GLSI opened at $15.91 on Friday. The business has a fifty day moving average of $19.51 and a two-hundred day moving average of $25.61. Greenwich LifeSciences, Inc. has a 52-week low of $15.52 and a 52-week high of $48.96.
Separately, Zacks Investment Research upgraded Greenwich LifeSciences from a “sell” rating to a “hold” rating in a report on Thursday.
About Greenwich LifeSciences (Get Rating)
Greenwich LifeSciences, Inc, a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent recurrence of breast cancer following surgery.
Read More
- Get a free copy of the StockNews.com research report on Greenwich LifeSciences (GLSI)
- 3 Resilient Stocks to Buy for Retirement
- MarketBeat: Week in Review 4/18 – 4/22
- Tractor Supply Company Reaps What It Sows
- Snap (NYSE: SNAP) Gives Investors A Mixed Bag
- MarketBeat Podcast: 3 Stocks Flashing Buy Signals
Receive News & Ratings for Greenwich LifeSciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Greenwich LifeSciences and related companies with MarketBeat.com's FREE daily email newsletter.